Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer

Colorectal cancer is very common worldwide and advanced colorectal cancer exhibited very poor clinical outcome. Oxaliplatin (OXP) is one of the principal chemotherapeutic agents in colorectal cancer treatment presenting impressive anti-tumor ability, limited by adverse effect in clinical practice. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuzhu, Yu, Ting, Liu, Xiaoxiao, He, Yihong, Deng, Lihong, Guo, Jiajuan, Hua, Yuanqi, Luo, Ting, Gao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788656/
https://www.ncbi.nlm.nih.gov/pubmed/29416788
http://dx.doi.org/10.18632/oncotarget.23507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788656/
https://www.ncbi.nlm.nih.gov/pubmed/29416788
http://dx.doi.org/10.18632/oncotarget.23507

Ejemplares similares